Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma - a Randomized Controlled Trial
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2019
Price : $35 *
At a glance
- Drugs Sorafenib (Primary) ; Phytomenadione; Phytomenadione
- Indications Carcinoma; Liver cancer
- Focus Therapeutic Use
- 25 Oct 2019 Status changed from active, no longer recruiting to completed.
- 17 Apr 2016 Primary endpoint has been met; (Overall Survival), according to the results published.
- 17 Apr 2016 Status changed from recruiting to active, no longer recruiting, according to the results published.